Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 3/20 | 0.43 |
| ▸ | SELL | P14151 | 2/20 | 0.43 |
| ▸ | SELE | P16581 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17008954 | 1.00 | CETP (0.51) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL18786584 | 1.00 | CETP (0.51) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL15477780 | 1.00 | CETP (0.51) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL1840886 | 1.00 | CETP (0.51) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL1614746 | 1.00 | CETP (0.51) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL3015938 | 0.99 | CETP (0.53) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL10782436 | 0.99 | CETP (0.53) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL19874824 | 0.99 | CETP (0.53) | CETPMAPK1SELPSELLSELE | |
| SCHEMBL7133066 | 0.95 | CETP (0.47) | CETPMAPK1 | |
| SCHEMBL436717 | 0.95 | CETP (0.47) | CETPMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160151483-A1 | BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160151483-A1 | BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS | SGMS2, SGMS1, UGCG | CETP 36/4885MAPK1 2665/4885SELP 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.